DK127786A - Fremgangsmaade til fremstilling af tgf-beta, dna og mrna, som koder for tgf-beta, samt replicerbare vektorer omfattende dna'en og vaertsceller indeholdende vektorerne - Google Patents

Fremgangsmaade til fremstilling af tgf-beta, dna og mrna, som koder for tgf-beta, samt replicerbare vektorer omfattende dna'en og vaertsceller indeholdende vektorerne Download PDF

Info

Publication number
DK127786A
DK127786A DK127786A DK127786A DK127786A DK 127786 A DK127786 A DK 127786A DK 127786 A DK127786 A DK 127786A DK 127786 A DK127786 A DK 127786A DK 127786 A DK127786 A DK 127786A
Authority
DK
Denmark
Prior art keywords
beta
tgf
dna
vectors
manufacturing
Prior art date
Application number
DK127786A
Other languages
English (en)
Other versions
DK175412B1 (da
DK127786D0 (da
Inventor
Rik Michel Andre Derynck
David Vannorman Goeddel
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DK127786D0 publication Critical patent/DK127786D0/da
Publication of DK127786A publication Critical patent/DK127786A/da
Application granted granted Critical
Publication of DK175412B1 publication Critical patent/DK175412B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK198601277A 1985-03-22 1986-03-20 Fremgangsmåde til fremstilling af TGF-beta, DNA og mRNA, som koder for TGF-beta, samt replicerbare vektorer omfattende DNA'en og værtsceller indeholdende vektorerne DK175412B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71514285A 1985-03-22 1985-03-22
US71514285 1985-03-22

Publications (3)

Publication Number Publication Date
DK127786D0 DK127786D0 (da) 1986-03-20
DK127786A true DK127786A (da) 1986-09-23
DK175412B1 DK175412B1 (da) 2004-09-27

Family

ID=24872822

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198601277A DK175412B1 (da) 1985-03-22 1986-03-20 Fremgangsmåde til fremstilling af TGF-beta, DNA og mRNA, som koder for TGF-beta, samt replicerbare vektorer omfattende DNA'en og værtsceller indeholdende vektorerne

Country Status (7)

Country Link
EP (1) EP0200341B1 (da)
JP (2) JPH0659230B2 (da)
AT (1) ATE99737T1 (da)
DE (1) DE3689495T2 (da)
DK (1) DK175412B1 (da)
IE (1) IE61119B1 (da)
IL (1) IL78197A (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989012101A1 (en) * 1988-06-08 1989-12-14 Genentech, Inc. NUCLEIC ACID ENCODING TGF-beta3 AND ITS USE
NZ222168A (en) * 1986-10-20 1991-05-28 Oncogene Science Inc Tumour growth inhibiting protein related to tgf-#b#1 and tgf-#b#2, preparation by genetic engineering methods, antibodies and pharmaceutical compositions
AU1340688A (en) * 1987-01-30 1988-08-24 Techne Corporation Transforming growth factor-beta
US4931548A (en) * 1987-01-30 1990-06-05 Techne Corporation Heterodimer form of transforming growth factor-beta
JPS6463395A (en) * 1987-05-04 1989-03-09 Oncogen Oncostatin m and novel composition having antitumor activity
AU1539188A (en) * 1987-05-04 1988-11-10 Bristol-Myers Squibb Company TGF-B2 and novel compositions having anti-neoplastic activity
EP0293785A3 (en) 1987-05-29 1990-05-02 Oncogen Limited Partnership Cloning and expression of simian transforming growth factor-ss1
US5221620A (en) * 1987-10-06 1993-06-22 Oncogen Cloning and expression of transforming growth factor β2
IL87877A0 (en) * 1987-10-06 1989-03-31 Oncogen Cloning and expression of transforming growth factor beta2
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
US5158934A (en) * 1989-09-01 1992-10-27 Genentech, Inc. Method of inducing bone growth using TGF-β
US5422340A (en) * 1989-09-01 1995-06-06 Ammann; Arthur J. TGF-βformulation for inducing bone growth
CA2070393A1 (en) * 1989-10-18 1991-04-19 Charles M. Cohen Biosynthetic constructs of tgf-beta
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
TW517059B (en) 1994-07-25 2003-01-11 Ciba Geigy Ag New process for the production of biologically active protein
ES2213221T3 (es) * 1996-07-29 2004-08-16 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Und Zum Vertrieb Von Pharmaka Mbh Factor de tipo egf de granulos de cromafina y factor neurotrofico derivado de celulas de glia con actividad promotora de la supervivencia sobre neuronas daergicas.
GB9822682D0 (en) * 1998-10-16 1998-12-09 Gemini Research Limited Diagnostic method and apparatus based on polymorphism in a TGF-B-Gene
WO2000054797A2 (en) 1999-03-17 2000-09-21 Novartis Ag Pharmaceutical compositions comprising tgf-beta
US7211271B2 (en) 2001-03-12 2007-05-01 The Regents Of The University Of California Method to improve hydroxyapatite implantation and stimulate bone regeneration
NZ550217A (en) 2004-03-31 2009-11-27 Genentech Inc Humanized anti-TGF-beta antibodies
GB0604938D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Proteins, nucleic acids and medicaments
GB0604964D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Protein folding
GB0604966D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Medicaments and proteins
SG176476A1 (en) 2006-11-02 2011-12-29 Daniel J Capon Hybrid immunoglobulins with moving parts
JP7125933B2 (ja) * 2017-05-02 2022-08-25 株式会社カネカ 免疫グロブリン結合活性を有するポリペプチドの回収精製法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0154434B1 (en) * 1984-02-17 1993-01-27 Genentech, Inc. Human transforming growth factor and precursor or fragment thereof, cells, dna, vectors and methods for their production, compositions and products containing them, and related antibodies and diagnostic methods

Also Published As

Publication number Publication date
DK175412B1 (da) 2004-09-27
IE61119B1 (en) 1994-10-05
ATE99737T1 (de) 1994-01-15
DE3689495D1 (de) 1994-02-17
JPH0659230B2 (ja) 1994-08-10
EP0200341A1 (en) 1986-11-05
EP0200341B1 (en) 1994-01-05
IE860743L (en) 1986-09-22
DK127786D0 (da) 1986-03-20
DE3689495T2 (de) 1994-06-01
JPH06169777A (ja) 1994-06-21
JPS61219395A (ja) 1986-09-29
IL78197A (en) 1991-07-18
JPH0763378B2 (ja) 1995-07-12
IL78197A0 (en) 1986-07-31

Similar Documents

Publication Publication Date Title
DK127786A (da) Fremgangsmaade til fremstilling af tgf-beta, dna og mrna, som koder for tgf-beta, samt replicerbare vektorer omfattende dna'en og vaertsceller indeholdende vektorerne
DK460882A (da) Dna-sekvens, der koder for humant immun-interferon, replicerbareudtrykkelsesmedier herfor, mikroorganisme- eller cellekulturer transformeret med saadanne og fremgangsmaade til fremstilling af et polypeptid, der omfatter aminosyresekvensen af humant immun-interferon
DK374686A (da) Knoglemorphogenetiske midler, fremgangsmaade til fremstilling deraf og dna-sekvenser, nucleinsyresonder og rekombinante udtrykkelsesmedier til anvendelse derved
DK239383A (da) Mikrobiologisk fremstillede alfa- og beta-interferoner, dna-sekvenser, der koder for disse interferoner, mikroorganismer, som indeholder denne genetiske information, og fremgangsmaade til deres fremstilling
DK198883A (da) Fremgangsmaade til fremstilling af menneskevaevs-plasminogen-aktivator, dna-sekvens der koder for denne aktivator, replicerbar udtrykkelsesvektor for dna-sekvensen og mikroorganisme eller cellekultur transformeret med udtrykkelsesvektoren
DE68927277D1 (de) CD40 kodierende DNA
DK166357C (da) Partikler med immunogene egenskaber svarende til hbs antigen samt vektorer og animalske celler til produktion af saadanne partikler
DK308586D0 (da) Dna-sekvens, der koder for et specifikt protein, rekombinantvektor, der omfatter sekvensen, og celler, der er transficerede til ekspression af proteinet
CA2091102A1 (en) Microsomal triglyceride transfer protein
ATE215988T1 (de) Vitamin-k-abhängige carboxylase
DK388789A (da) Hybridderivat af humant protein d, dets fremstilling og anvendelse samt dna, som koder derfor, og genstruktur og vaertscelle indeholdende denne dna
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
GB9215232D0 (en) Vaccines
SE7806087L (sv) Forfarande for rening av nukleotidsekvenser lempliga som syntetiseringsmall i bakterier, mikroorganism innefattande dylik nukleotidsekvens samt rekombinant dna-overforingsvektor innefattande dylik nukleotid
ATE188997T1 (de) Klonierung von malaria-spezifischen dna- sequenzen:isolierung des gens für das 140 kd protein
ATE119206T1 (de) Dmd-sonden.
IT8521507A0 (it) Vettore di clonaggio, molecole di dna ricombinante, ceppi di bacillus subtilis trasformati con dette molecole e metodi per l'espressione di geni eterologhi e produzione e secrezione di proteine codificate da detti geni.
NO971359L (no) Humant galaktokinase-gen

Legal Events

Date Code Title Description
PUP Patent expired